{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:00:00Z","timestamp":1793138400334,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["EU734791"],"award-info":[{"award-number":["EU734791"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["H2020-MSCA-RISE-2016"],"award-info":[{"award-number":["H2020-MSCA-RISE-2016"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013511","name":"Silm\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["IUT19-18"],"award-info":[{"award-number":["IUT19-18"]}],"id":[{"id":"10.13039\/501100013511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["EU734791"],"award-info":[{"award-number":["EU734791"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015738","name":"Mary och Georg C. Ehrnrooths Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ebiom.2021.103211","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T21:54:09Z","timestamp":1611352449000},"page":"103211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Identification of two highly antigenic epitope markers predicting multiple sclerosis in optic neuritis patients"],"prefix":"10.1016","volume":"64","author":[{"given":"Helle","family":"Sadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Pihlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariliis","family":"Jaago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nade\u017eda","family":"Pupina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"R\u00e4hni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarja","family":"Toots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Vaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne K.","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Siuko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti J.","family":"Tienari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaia","family":"Palm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ebiom.2021.103211_bib0001","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham","year":"2013","journal-title":"Nat Genet"},{"issue":"Pt 1","key":"10.1016\/j.ebiom.2021.103211_bib0002","first-page":"365","article-title":"EBV and autoimmunity","volume":"390","author":"Ascherio","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ebiom.2021.103211_bib0003","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103211_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103211_bib0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann Neurol"},{"issue":"Pt 7","key":"10.1016\/j.ebiom.2021.103211_bib0006","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/brain\/124.7.1325","article-title":"Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response","volume":"124","author":"Derfuss","year":"2001","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103211_bib0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/1531-8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M","article-title":"Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis","volume":"46","author":"Sriram","year":"1999","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103211_bib0008","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/WNL.56.9.1168","article-title":"CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens","volume":"56","author":"Yao","year":"2001","journal-title":"Neurology"},{"issue":"2\u20133","key":"10.1016\/j.ebiom.2021.103211_bib0009","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0022-510X(85)90067-X","article-title":"Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?","volume":"71","author":"Felgenhauer","year":"1985","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103211_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.410080305","article-title":"Viral and bacterial antibody responses in multiple sclerosis","volume":"8","author":"Vartdal","year":"1980","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103211_bib0011","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/ene.12435","article-title":"Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis","volume":"21","author":"Alenda","year":"2014","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103211_bib0012","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-005-0794-z","article-title":"Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response","volume":"252","author":"Derfuss","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.ebiom.2021.103211_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.coviro.2014.09.016","article-title":"Evidence linking HHV-6 with multiple sclerosis: an update","volume":"9","author":"Leibovitch","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2021.103211_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2011.06.012","article-title":"Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid","volume":"237","author":"Virtanen","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103211_bib0015","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ebiom.2021.103211_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ebiom.2018.01.043","article-title":"Prostaglandin D2 receptor DP1 antibodies predict vaccine-induced and spontaneous narcolepsy type 1: large-scale study of antibody profiling","volume":"29","author":"Sadam","year":"2018","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103211_bib0017","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1172\/JCI63842","article-title":"B cell exchange across the blood-brain barrier in multiple sclerosis","volume":"122","author":"von Budingen","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103211_bib0018","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ana.24088","article-title":"In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses","volume":"75","author":"Bankoti","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103211_bib0019","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.29.1.60","article-title":"Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation","volume":"29","author":"Leibowitz","year":"1966","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103211_bib0020","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103211_bib0021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jinf.2019.10.017","article-title":"A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls","volume":"80","author":"Maple","year":"2020","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103211_bib0022","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.25532","article-title":"Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort","volume":"86","author":"Munger","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2021.103211_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102807","article-title":"Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study","volume":"56","author":"Bittner","year":"2020","journal-title":"EBioMedicine"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:32:44Z","timestamp":1778873564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":23,"alternative-id":["S2352396421000049"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103211","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of two highly antigenic epitope markers predicting multiple sclerosis in optic neuritis patients","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103211"}}